Michael C. Stauder, M.D.
Department of Breast Radiation Oncology, Division of Radiation Oncology
About Dr. Stauder
Dr. Stauder is a Professor in the Department of Breast Radiation Oncology at MD Anderson Cancer Center in Houston, Texas. The Department of Breast Radiation Oncology represents decades of breast cancer expertise by ten radiation oncology clinicians, and a specialized team of breast radiotherapy nurses, physicists, therapists and dosimetrists. We treat all left sided and selected right-sided breast cancer using deep-inspiration breath hold to eliminate the heart from the radiation field. We offer every type of radiotherapy technology including proton therapy, always selected and personalized to each case. We are constantly working to improve radiotherapy for breast cancer and offer numerous clinical trial opportunities designed to make radiotherapy easier and more effective with fewer side effects.
Dr. Stauder is a member of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic. His research focus centers on the design and development of prospective clinical trials for evaluation of immunotherapy in combination with radiation especially in triple negative, inflammatory and (oligo) metastatic hormone positive breast cancer. He is also interested in the development of novel radio sensitizers, new image guided radiotherapy techniques and functional imaging for the effective treatment of breast cancer and other solid tumors. Other interests also include identifying molecular epidemiological factors that predict for treatment-related side effects and quality-of-life difficulties in people with breast cancer.
Dr. Stauder is a member of several national and international radiation-therapy related societies and organizations. He has been involved with several educational and mentorship activities including resident training and global academic programs. Dr. Stauder has authored many articles, editorials, abstracts and book chapters.
Dr. Stauder earned his undergraduate degree from The University of Chicago and earned his medical degree from University of Wisconsin School of Medicine and Public Health. He then completed his clinical internship year at The University of Illinois-Chicago and a clinical residency in Radiation Oncology at Mayo Clinic, Rochester, MN.
Present Title & Affiliation
Primary Appointment
Professor, Department of Breast Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Associate Professor, University of Houston, Houston, TX
Clinical Interests
Inflammatory Breast Cancer, Triple Negative Breast Cancer, Repeat radiation, Translational Clinical Trials
Education & Training
Degree-Granting Education
| 2007 | University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, US, MD |
| 1999 | The University of Chicago, Chicago, Illinois, US, Biological Sciences, BA |
Postgraduate Training
| 2008-2012 | Clinical Residency, Radiation Oncology, Mayo Clinic, Rochester, Minnesota |
| 2007-2008 | Clinical Internship, University of Illinois-Chicago, Evanston, Illinois |
Board Certifications
| 2014 | American Board of Radiology |
Experience & Service
Academic Appointments
Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2024
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2018
Administrative Appointments/Responsibilities
Education Director (Department level), Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Section Director, Department of Breast Radiation Oncology, MD Anderson Cancer Network, Houston, TX, 2016 - Present
Residency/Fellowship Site Director: Breast, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present
Other Appointments/Responsibilities
Member of Advisory Council, Native American Center for Health Professions at the University of Wisconsin School of Medicine and Public Health, Madison, WI, 2014 - Present
Consultant, MD Anderson Physicians Network, Houston, TX, 2014 - Present
Institutional Committee Activities
Member, MD Anderson Institutional Diversity Council, 2016 - 2019
Member, Quality and Safety Committee, Division of Radiation Oncology, 2015 - 2018
Member, Project ECHO: Africa Committee, 2015 - 2020
Honors & Awards
| 2015 | Methods in Clinical Cancer Research Course, AACR |
| 2014 | Honorary Fellowship, Native American Center for Health Professions at the University of Wisconsin School of Medicine and Public Health |
| 2012 | Roentgen Resident/Fellow Research Award, Mayo Clinic |
| 2011 | Annual Meeting Merit Award, ASCO |
| 2011 | Chief Resident, Radiation Oncology, Mayo Clinic |
| 2011 | 2011 Gastrointestinal Cancers Symposium Merit Award |
| 2009 | Academic Radiology Program Honorarium, RSNA/ARRS |
| 2007 | Graduation with Honors in Research, University of Wisconsin |
| 2007 | Chief Resident, Transitional Year Program, Saint Francis Hospital |
| 2006 | Clerkship Diversity Scholarship, Mayo Clinic |
| 2005 | Minority Scholar Award in Cancer Research, AACR |
| 2004 | General Clinical Research Center Fellowship, University of Wisconsin |
| 2004 | Shapiro Excellence in Student Research Award, University of Wisconsin |
| 2003 | Merit Scholarship (full tuition), University of Wisconsin Medical School |
Selected Publications
Peer-Reviewed Articles
- Shaitelman SF, Le-Petross H, Raso MG, Swanson DM, Schalck AP, Contreras A, Yang F, Muruganandham M, Zhao GZ, Sawakuchi GO, Kim LH, Batra H, Smith BD, Stauder MC, Woodward WA, Reddy JP, Litton JK, Thompson A, Bedrosian I, Mitten EA. PRECISE: Preoperative Radiotherapy to Elicit Critical Immune Stimulating Effects - A Phase II Clinical Trial. Int J Radiat Oncol Biol Phys. e-Pub 2024. PMID: 39147206.
- Yoder AK, Xu T, Youssef P, DeSnyder S, Marqueen KE, Isales L, Lin R, Smith BD, Woodward WA, Stauder MC, Strom EA, Aldrich MB, Shaitelman SF. Association between symptom burden and early lymphatic abnormalities after regional nodal irradiation for breast cancer. Pract Radiat Oncol 14(3):e180-e189, 2024. e-Pub 2024. PMID: 37914083.
- Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast 68:205-215, 2023. e-Pub 2023. PMID: 36863241.
- Reddy JP, Lei X, Bloom ES, Reed VK, Schlembach PJ, Arzu I, Mayo L, Chun SG, Ahmad NR, Stauder MC, Gopal R, Kaiser K, Fang P, Smith BD, Investigators OT. Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase II Tial of Daily Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 115(3):629-644, 2023. e-Pub 2023. PMID: 36216274.
- Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol 29(Suppl 3):620-621, 2022. e-Pub 2022. PMID: 36104531.
- Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol 29(10):6381-6392, 2022. e-Pub 2022. PMID: 35834145.
- Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat 195(1):33-41, 2022. e-Pub 2022. PMID: 35816269.
- Andring LM, Diao K, Sun S, Patel M, Whitman GJ, Schlembach P, Arzu I, Joyner MM, Shaitelman SF, Hoffman K, Stauder MC, Smith BD, Woodward WA. Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement. Int J Radiat Oncol Biol Phys 113(3):552-560, 2022. e-Pub 2022. PMID: 35248602.
- Corrigan KL, Lei X, Ahmad N, Arzu I, Bloom E, Chun SG, Goodman C, Hoffman KE, Joyner M, Mayo L, Mitchell M, Nead KT, Perkins GH, Reed V, Reddy JP, Schlembach P, Shaitelman SF, Stauder MC, Strom EA, Tereffe W, Wiederhold L, Woodward WA, Smith BD. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer. Adv Radiat Oncol 7(2):100877, 2022. e-Pub 2022. PMID: 35387420.
- Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Outcomes after breast radiotherapy in a diverse patient cohort with a germline BRCA1/2 mutation. Int J Radiat Oncol Biol Phys 112(2):426-436, 2022. e-Pub 2022. PMID: 34610390.
- Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Breast radiotherapy-related treatment outcomes in patients with or without germline mutations on multigene panel testing. Int J Radiat Oncol Biol Phys 112(2):437-444, 2022. e-Pub 2022. PMID: 34582940.
- Weng JK, Lei X, Schlembach P, Bloom ES, Shaitelman SF, Arzu IY, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys 111(2):360-370, 2021. e-Pub 2021. PMID: 33992718.
- Pasalic D, Strom EA, Allen PK, Williamson TD, Poenisch F, Amos RA, Woodward WA, Stauder MC, Shaitelman SF, Smith BD, Perkins GH, Tereffe W, Hoffman KE. Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase II Trial. Int J Radiat Oncol Biol Phys 109(2):441-448, 2021. e-Pub 2021. PMID: 32946965.
- Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Piotrowski M, Fuller CD, Stauder MC, Shaitelman SF, Perkins GH, Woodward WA, Giordano SH, Smith BD, Ludmir EB. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. Oncologist 25(6):e990-e992, 2020. e-Pub 2020. PMID: 32272505.
- Stecklein SR, Rosso KJ, Nuanjing J, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Teshome M, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA. Excellent Locoregional Control in Inflammatory Breast Cancer with a Personalized Radiotherapy Approach. Pract Radiat Oncol 9(6):402-409, 2019. e-Pub 2019. PMID: 31132433.
- Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder MC, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement. Int J Radiat Oncol Biol Phys 104(3):574-581, 2019. e-Pub 2019. PMID: 30851348.
- Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol 4(12):1751-1757, 2018. e-Pub 2018. PMID: 30027292.
- Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol:JCO1800317. e-Pub 2018. PMID: 30379626.
- Chance WW, Ortiz-Ortiz KJ, Liao KP, Zavala Zegarra DE, Stauder MC, Giordano SH, Tortolero-Luna G, Guadagnolo BA. Underuse of Radiation Therapy After Breast Conservation Surgery in Puerto Rico: A Puerto Rico Central Cancer Registry-Health Insurance Linkage Database Study. J Glob Oncol 4(4):1-9, 2018. e-Pub 2018. PMID: 30241162.
- Matsuda N, Wang X, Lim B, Krishnamurthy S, Alvarez RH, Willey JS, Parker CA, Song J, Shen Y, Hu J, Wu W, Li N, Babiera GV, Murray JL, Arun BK, Brewster AM, Reuben JM, Stauder MC, Barnett CM, Woodward WA, Le-Petross HTC, Lucci A, DeSnyder SM, Tripathy D, Valero V, Ueno NT. Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer. JAMA Oncol 4(9):1207-1213, 2018. e-Pub 2018. PMID: 29879283.
- Van Wyhe RD, Caudle AS, Shaitelman SF, Perkins GH, Buchholz TA, Hoffman KE, Strom EA, Smith BD, Tereffe W, Woodward WA, Stauder MC. A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer. Adv Radiat Oncol 3(3):252-257, 2018. e-Pub 2018. PMID: 30197937.
- Ovalle V, Strom EA, Shaitelman S, Hoffman K, Amos R, Perkins G, Tereffe W, Smith BD, Stauder MC, Woodward W. Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects. Cancers (Basel) 10(4), 2018. e-Pub 2018. PMID: 29642467.
- Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 9(8):1437-1447, 2018. e-Pub 2018. PMID: 29721054.
- Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol 24(10):2965-2971, 2017. e-Pub 2017. PMID: 28766219.
- Moreno AC, Lin YH, Bedrosian I, Shen Y, Stauder MC, Smith BD, Buchholz TA, Babiera GV, Woodward WA, Shaitelman SF. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis. Adv Radiat Oncol 2(3):291-300, 2017. e-Pub 2017. PMID: 29114595.
- Shaitelman SF, Stauder MC, Allen P, Reddy S, Lakoski S, Atkinson B, Reddy J, Amaya D, Guerra W, Ueno N, Caudle A, Tereffe W, Woodward WA. Impact of Statin Use on Outcomes in Triple Negative Breast Cancer. J Cancer 8(11):2026-2032, 2017. e-Pub 2017. PMID: 28819403.
- Stauder MC, Caudle AS, Allen PK, Shaitelman SF, Smith BD, Hoffman KE, Buchholz TA, Chavez-Macgregor M, Hunt KK, Meric-Bernstam F, Woodward WA. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys 96(3):637-644, 2016. e-Pub 2016. PMID: 27681760.
- Vila J, Mittendorf EA, Farante G, Bassett RL, Veronesi P, Galimberti V, Peradze N, Stauder MC, Chavez-MacGregor M, Litton JF, Huo L, Kuerer HM, Hunt KK, Caudle AS. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer. Ann Surg Oncol 23(11):3501-3509, 2016. e-Pub 2016. PMID: 27216742.
- Sio TT, Wilson ZC, Stauder MC, Bhatia S, Martenson JA, Quevedo JF, Schomas DA, Miller RC. Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience. Am J Clin Oncol. e-Pub 2016. PMID: 24879469.
- Swanick CW, Lei X, Shaitelman SF, Schlembach PJ, Bloom ES, Fingeret MC, Strom EA, Tereffe W, Woodward WA, Stauder MC, Dvorak T, Thompson AM, Buchholz TA, Smith BD. Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated versus Hypofractionated Whole-Breast Irradiation. Cancer 122(18):2886-94, 2016. e-Pub 2016. PMID: 27305037.
- Ovalle V, Strom EA, Godby J, Shaitelman SF, Stauder MC, Amos RA, Kuerer HM, Woodward WA, Hoffman KE. Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly?. Int J Radiat Oncol Biol Phys 95(1):49-51, 2016. e-Pub 2016. PMID: 27084625.
- Bishop AJ, Ensor J, Moulder SL, Shaitelman SF, Edson MA, Whitman GJ, Bishnoi S, Hoffman KE, Stauder MC, Valero V, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy. Cancer 121(24):4324-4332, 2015. e-Pub 2015. PMID: 26348887.
- Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol 1(7):931-941, 2015. e-Pub 2015. PMID: 26247543.
- Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ. Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys 93(1):102-110, 2015. e-Pub 2015. PMID: 26279028.
- Strom EA, Amos RA, Shaitelman SF, Kerr MD, Hoffman KE, Smith BD, Tereffe W, Stauder MC, Perkins GH, Amin MD, Wang X, Poenisch F, Ovalle V, Buchholz TA, Babiera G, Woodward WA. Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique. Pract Radiat Oncol 5(4):e283-290, 2015. e-Pub 2015. PMID: 25804105.
- Thaker NG, Hoffman KE, Stauder MC, Shaitelman SF, Strom EA, Tereffe W, Smith BD, Perkins GH, Huo L, Munsell MF, Pusztai L, Buchholz TA, Woodward WA. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. Springerplus 4:36, 2015. e-Pub 2015. PMID: 25674496.
- Stauder MC, Woodward W. Local-Regional Treatment of the Patient With Inflammatory Breast Cancer. Curr Breast Cancer Rep 7(1):37-42, 2015. e-Pub 2015.
- Brown L, Harmsen W, Blanchard M, Goetz M, Jakub J, Mutter R, Petersen I, Rooney J, Stauder MC, Yan E, Laack N. Once Daily Radiation Therapy for Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys 84(3):S249, 2014. e-Pub 2014. PMID: 24721591.
- Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez RH, Hoffman KE, Perkins GH, Strom EA, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. Springerplus 3:166, 2014. e-Pub 2014. PMID: 24711988.
- Stauder MC, Romero Y, Kabat B, Atherton PJ, Geno D, Deschamps C, Jatoi A, Sloan JA, Botros M, Jung KW, Arora AS, Miller RC, Consortium ER. Overall survival and self-reported fatigue in patients with esophageal cancer. Support Care Cancer 21(2):511-519, 2013. e-Pub 2013. PMID: 22842921.
- Stauder MC, Rooney JW, Neben-Wittich MA, Garces YI, Olivier KR. Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy. Radiat Oncol 8(1):167, 2013. e-Pub 2013. PMID: 23829565.
- Hallemeier CL, Stauder MC, Miller RC, Garces YI, Foote RL, Sarkaria JN, Bauer HJ, Mayo CS, Olivier KR. Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes. J Radiosurg SBRT 2(3):225-233, 2013. e-Pub 2013. PMID: 29296365.
- Stauder MC, Ni Laack N, Ahmed KA, Link MJ, Schomberg PJ, Pollock BE. Stereotactic radiosurgery for patients with recurrent intracranial ependymomas. J Neurooncol 108(3):507-512, 2012. e-Pub 2012. PMID: 22437346.
- Cai L, Stauder MC, Zhang YJ, Poortmans P, Li YX, Constantinou N, Thariat J, Kadish SP, Nguyen TD, Kirova YM, Ghadjar P, Weber DC, Bertran VT, Ozsahin M, Mirimanoff RO. Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study. Int J Radiat Oncol Biol Phys 83(1):284-291, 2012. e-Pub 2012. PMID: 22079728.
- Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys 82(5):e803-809, 2012. e-Pub 2012. PMID: 22330988.
- Stauder MC, Laack NN, Moir CR, Schomberg PJ. Excellent local control and survival after intraoperative and external beam radiotherapy for pediatric solid tumors: long-term follow-up of the Mayo Clinic experience. J Pediatr Hematol Oncol 33(5):350-355, 2011. e-Pub 2011. PMID: 21602722.
- Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, Miller RC, Brown PD, Bauer HJ, Garces YI. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol 99(2):166-171, 2011. e-Pub 2011. PMID: 21571384.
- Stauder MC, Miller RC. Stereotactic body radiation therapy (SBRT) for unresectable pancreatic carcinoma. Cancers 2(3):1565-1575, 2010. e-Pub 2010.
- Neben-Wittich MA, Stauder MC, Quevedo F, Corsini MM, Iott M, Miller RC. Adjuvant radiotherapy and chemotherapy for resected pancreatic adenocarcinoma: Review of current evidence. European Journal of Clinical and Medical Oncology 2(1):89-96, 2010. e-Pub 2010.
- Hank JA, Gan J, Ryu H, Ostendorf A, Stauder MC, Sternberg A, Albertini M, Lo KM, Gillies SD, Eickhoff J, Sondel PM. Immunogenicity of the hu14.18-IL2 immunocytokine molecule in adults with melanoma and children with neuroblastoma. Clin Cancer Res 15(18):5923-5930, 2009. e-Pub 2009. PMID: 19737959.
- Chance WW, Ortiz-Ortiz KJ, K-P L, Zegarra DEZ, Stauder MC, Giordano SH, et al. Underuse of Radiation Therapy After Breast Conservation Surgery in Puerto Rico: A Puerto Rico Central Cancer Registry–Health Insurance Linkage Database Study. Journal of Global Oncology.
Manuals, Teaching Aids, Other Teaching Publications
- Stauder MC, Tereffe W. Radiation Therapy for Breast Cancer: Care by GE Health Care, 2017.
Other Articles
- Stauder MC Radiation for inflammatory breast cancer: Updates. Int Rev Cell Mol Biol 384:25-46, 2024. PMID: 38637098.
- Corrigan KL, Woodward WA, Stauder MC How should radiation be done for inflammatory breast cancer patients?-a narrative review of modern literature. Chin Clin Oncol 10(6):60, 2021. PMID: 35016514.
- Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, Ueno NT, Lim B Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer. Surg Clin North Am 98(4):787-800, 2018. PMID: 30005774.
- Fouad TM, Barrera AMG, Reuben JM, Lucci A, Woodward WA, Stauder MC, Lim B, DeSnyder SM, Arun B, Gildy B, Valero V, Hortobagyi GN, Ueno NT Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system. Lancet Oncol 18(4):e228-e232, 2017. PMID: 28368261.
Editorials
- Stauder MC, Woodward WA. Prophylactic use of pentoxifylline (Trental) and vitamin E to prevent capsular contracture after implant reconstruction in patients requiring adjuvant radiation. Breast Disease 27(4):289-290, 2016.
- Stauder MC. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Breast Disease 27(4):281-282, 2016.
- Stauder MC. Evaluating the Effects of Aluminum-Containing and Non-Aluminum Containing Deodorants on Axillary Skin Toxicity During Radiation Therapy for Breast Cancer: A 3-Armed Randomized Controlled Trial. Breast Disease 26(2):163-4, 2015.
- Stauder MC. Hypofractionated Radiotherapy for Breast Ductal Carcinoma In Situ. Breast Diseases: A Year Book Quarterly 25(3):270-271, 2014.
- Stauder MC. Commentary on: "Correlation of in vitro lymphocyte and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer". Breast Diseases: A Year Book Quarterly 24(2), 2013.
- Stauder MC. Commentary on: "Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial". Breast Diseases: A Year Book Quarterly 24(4):384-385, 2013.
- Stauder MC. Commentary on: "Triple Negative Breast Cancer is Associated with an Increased Risk of Residual Invasive Carcinoma After Lumpectomy". Breast Diseases: A Year Book Quarterly 24(1):46-47, 2013.
- Stauder MC. Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers. Breast Diseases: A Year Book Quarterly.
Abstracts
- Shaitelman SF, Gandhi A, Xu T, DeSnyder S, Smith GL, Lin R, Barcenas C, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I. Prospective, Longitudinal Assessment of Lymphedema-related Quality of Life for Locally Advanced Breast Cancer Patients: A Foundation for Needed Elements in a Lymphedema Screening Program. American Radium Society 2022 Annual Meeting, 2022. e-Pub 2022.
- Moreno AC, Lin H, Bedrosian I, Smith BD, Babiera G, Stauder MC, et al. Effect of Regional Nodal Irradiation on Overall Survival in Patients With High-risk Invasive Breast Cancer: A National Cancer Data Base Analysis. International Journal of Radiation Oncology Biology Physics, 2016. e-Pub 2016.
- Cai CY, Calhoun JD, Kanke J, Melancon AD, Collado D, Gifford K, et al. Defining Cost as a First Step to Determining the Value of Radiation Services Provided: Utilizing Time-Driven Activity-Based Costing to Ascertain True Costs in Breast Cancer Radiation Treatment Planning. International Journal of Radiation Oncology Biology Physics, 2016. e-Pub 2016.
- Shaitelman SF, Stauder MC, Allen PK, Reddy S, Lakoski SG, Atkinson BJ, et al. Impact of Statin Use on Outcomes in Triple-Negative Breast Cancer. International Journal of Radiation Oncology Biology Physics, 2016. e-Pub 2016.
- Stauder MC, Shaitelman SF, Allen PK, Brewster AM, Arun BK, Woodward WA, Buchholz TA, Wang LE. Gamma-ray induced mutagen sensitivity and overall survival in young women with breast cancer. Cancer Research 75(9), 2015. e-Pub 2015.
- Vila J, Bassett RL, Mittendorf EA, Bedrosian I, Shaitelman SF, Stauder MC, Chavez-Mac Gregor M, Litton JK, Yang WT, et al HL. A nomogram to predict axillary response to neoadjuvant chemotherapy in clinically node positive breast patients. Journal of Clinical Oncology 33(15), 2015. e-Pub 2015.
- Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez RH, Hoffman KE, et. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. SpringerPlus, 2014. e-Pub 2014.
- Shaitelman SF, Buchholz TA, Hunt KK, Hortobagyi GN, Schlembach P, Arzu I, Bloom E, Chronowski G, Dvorak T, et al GE. Hypofractionated Whole Breast Irradiation Results in Less Acute Toxicity and Improved Quality of Life at Six Months Compared to Conventionally Fractionated Whole Breast Irradiation: Results of a Randomized Trial. International Journal of Radiation Oncology Biology Physics 90(5):1264-1264, 2014. e-Pub 2014.
- Stauder MC, Laack NNI, Ahmed KA, Link MJ, Schomberg PJ, Pollock BE. Stereotactic radiosurgery for patients with recurrent intracranial ependymomas. Journal of Neuro-Oncology, 2012. e-Pub 2012.
- Stauder MC, Roden AC, Wigle D, Price KA, Garces YI, Olivier KR. Radiologic Tumor Regression and Correlation with Pathologic Findings after Neoadjuvant Therapy for Non-small Cell Lung Cancer. Journal Thoracic Oncology, 2012. e-Pub 2012.
- Cai L, Stauder MC, Zhang YJ, Poortmans P, Li YX, Constantinou N. Early stage primary bone lymphoma: A retrospective, multicenter rate cancer network study. Strahlentherapie Und Onkologie 187:538-538, 2011. e-Pub 2011.
- Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Olivier KR, Laack NN. Clinical Outcomes of Single and Multifractionated SBRT Schedules for Spinal Metastases. International Journal of Radiation Oncology Biology Physics, 2011. e-Pub 2011.
- Stauder MC, Romero Y, Kabat B, Atherton PJ, Fredericksen MB, Deschamps C, Jatoi A, Sloan JA, Botros M, Miller RC. Analysis of overall survival and self-reported fatigue in patients with esophageal cancer: A Mayo Clinic esophageal adenocarcinoma and Barrett's Esophagus Registry Consortium study. J Clin Oncol 29, 2011. e-Pub 2011.
- Stauder MC, Romero Y, Kabat B, Atherton PJ, Fredericksen MB, Deschamps C, et al. Analysis of overall survival and self-reported fatigue in patients with locally advanced esophageal cancer: A Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium study. Journal of Clinical Oncology, 2011. e-Pub 2011.
- Cai L, Stauder MC, Zhang YJ, Poortmans P, Li YX, Constantinou N, et al. Early Stage Primary Bone Lymphoma - A Retrospective, Multicenter Rare Cancer Network (RCN) Study. Strahlentherapie Und Onkologie, 2011. e-Pub 2011.
- Stauder MC, Romero Y, Kabat B, Atherton PJ, Fredericksen MB, Deschamps C, et al. Patient-reported fatigue and overall survival in locally advanced esophageal cancer: A Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium study. Journal of Clinical Oncology, 2011. e-Pub 2011.
- Stauder MC, Olivier KR, Macdonald OK, Lafata K, Mayo CS, Bauer HJ, et al. Maximum PTV Dose Predicts for Radiation Pneumonitis Following Lung Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology Biology Physics, 2011. e-Pub 2011.
- Cai L, Stauder MC, Zhang YJ, Poortmans P, Li YX, Constantinou N, et al. Early Stage Primary Bone Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study. International Journal of Radiation Oncology Biology Physics, 2010. e-Pub 2010.
- Stauder MC, Laack NN, Link MJ, Pollock BE, Schomberg PJ. GAMMA Knife Radiosurgery for Recurrent Intracranial Ependymoma. Journal of Neuro-Oncology, 2010. e-Pub 2010.
- Stauder MC, Laack NN, Link MJ, Pollock BE, Schomberg PJ. Stereotactic body radiation therapy in spinal metastases. Neuro-Oncology 12:106-106, 2010. e-Pub 2010.
- Stauder MC, Laack NN, Link MJ, Pollock BE, Schomberg PJ. Gamma Knife Radiosurgery for Recurrent Intracranial Ependymoma. Neuro-Oncology 12:106-106, 2010. e-Pub 2010.
- Hank JA, Gan J, Ryu H, Ostendorf A, Stauder MC, Sternberg A, et al. Immunogenicity of the Hu14.18-IL2 Immunocytokine Molecule in Adults With Melanoma and Children With Neuroblastoma. Clinical Cancer Research, 2009. e-Pub 2009.
- Hank J, Stauder MC, Sternberg A, Kagan M, Gan J, Albertini M, Lo KM, Gillies S, Sondel P. The functional effects of anti-hu14.18 antibody activity found in the serum of patients following IV infusion of immunocytokine (IC) hu14.18-IL2 for treatment of melanoma. Proc Amer Assoc Cancer Res 46, 2005. e-Pub 2005.
- Swanick CW, Lei X, Shaitelman SF, Schlembach PJ, Bloom ES, Fingeret M, et al. Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. International Journal of Radiation Oncology Biology Physics.
- Van Wyhe RD, Shaitelman SF, Caudle AS, Hoffman KE, Perkins GH, Tereffe W, et al. Invasive Lobular Carcinoma Predicts for an Increased Likelihood of Surgical Upstaging Requiring Post-Mastectomy Radiation Therapy. International Journal of Radiation Oncology Biology Physics.
Book Chapters
- Stauder MC, Garces YI. Prophylactic Cranial Irradiation. In: Advances in Radiation Oncology of Lung Cancer, 2nd Edition. Springer-Verlag.
- Lim B, Stauder MC, Woodward WA, Rucci A, Ueno NT. Inflammatory Breast Cancer, How We Treat in MD Anderson. In: Breast Cancer. 3rd.
Selected Presentations & Talks
Local Presentations
- 2025. Decision Making for Adjuvant XRT. Invited. Breast Surgical Oncology APP Clinical Care Discussion Series. Houston, Texas, US.
- 2025. Review of CDH Breast Protocols. Invited. Cancer Diseases Hospital Zambia Planning Skills Project – ZaPS. Houston, Texas, US.
- 2025. Review of Applied Anatomy of the Breast. Invited. Cancer Diseases Hospital Zambia Planning Skills Project – ZaPS. Houston, Texas, US.
- 2022. Epidemiology, Systems Biology Approaches and Health Disparities. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2022. Biology & Treatment Decision-Making in Node positive Breast Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2022. Case Presentations. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2022. MCACC Guidelines & Network Adoption. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2022. VMAT Contouring. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2022. Locally Advanced Breast Contouring/Planning: IMRT/VMAT, Review RTOG, EORTC and Radcomp atlases. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2020. IBC Panel Debate: Local Therapy issues in IBC and MBC. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2020. Locally Advanced Breast Contouring/Planning: IMRT/VMAT, Review RTOG, EORTC and Radcomp atlases. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2020. Radiation nodal contouring for patients with IBC. Conference. Inflammatory Breast Cancer Program. Houston, TX, US.
- 2018. Management of the Node Positive Axilla. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Planning Topics: DIBH, electrons, SCV fields and contouring. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Discussion of ongoing implementation of MDACC standards at member institutions. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Multidisciplinary Planning Conference. Conference. MD Anderson Cancer Network. Houston, TX, US.
- 2018. Multidisciplinary Planning Conference. Conference. MD Anderson Cancer Network. Houston, TX, US.
- 2018. Multidisciplinary Planning Conference. Conference. MD Anderson Cancer Network. Houston, TX, US.
- 2017. Radiation Therapy in IBC. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2016. Breast and Thoracic - Stump the Professor. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2016. Management of Lymph Node Positive Breast Cancer (SAM). Conference. University of Texas MD Anderson Cancer Center. houston, TX, US.
Regional Presentations
- 2010. Poster Presentation: Gamma knife radiosurgery for recurrent ependymoma. Conference. Mayo Clinic. Rochester, MN, US.
- 2008. Rare primary site of carcinoid syndrome. Conference. Midwest Regional Meeting of the Society of General Internal Medicine. Chicago, IL, US.
- 2004. Evaluation of human anti-human antibody responses in melanoma patients treated with hu14.18-IL2 immunocytokine. Conference. University of Wisconsin School of Medicine and Public Health. Madison, WI, US.
National Presentations
- 2025. 21st Oncology Update: Advances and Controversies- De-escalation of Radiation Therapy in Early Stage Breast Cancer. Invited. Steamboat. Steamboat Springs, CO, US.
- 2017. Oral Presentation: Nijmegen breakage syndrome 1 (NBS1) gene polymorphism and overall survival in breast cancer. Invited. American Society for Radiation Oncology 59th Annual Meeting. San Diego, CA, US.
- 2017. Oral Presentation: Invasive Lobular Carcinoma Predicts for an Increased Likelihood of Surgical Upstaging Requiring Post-Mastectomy Radiation Therapy. Invited. Young Oncologist Essay Award. Colorado Springs, CO, US.
- 2014. Poster Presentation:Hypofractionated Whole Breast Irradiation Results in Less Acute Toxicity and Improved Quality of Life at 6 months Compared to Conventionally Fractionated Whole Breast Irradiation: Results of a Randomized Trial. Invited. 56th ASTRO Annual Meeting. San Francisco, CA, US.
- 2014. Poster Presentation: Toward Developing Survivorship Care Plans for Breast Cancer Patients at High Risk for Radiation related Cardiac Effects. Invited. 56th ASTRO Annual Meeting. San Francisco, CA, US.
- 2014. Poster Presentation: Post-mastectomy Radiotherapy After Positive Sentinel Lymph Node Biopsy and Completion Axillary Lymph Node Dissection. Invited. 56th ASTRO Annual Meeting. San Francisco, CA, US.
- 2014. Digital Poster Presentation:The Role of Ultrasound of the Regional Nodal Basins in Staging Patients with Triple Negative Breast Cancer: Implications for Local-regional Treatment. Invited. 56th ASTRO Annual Meeting. San Francisco, CA, US.
- 2012. Poster Presentation: Radiologic tumor regression and pathologic correlation after neoadjuvant therapy for non-small cell lung cancer. Conference. 54th Annual Meeting of the American Society for Radiation Oncology. Boston, MA, US.
- 2012. Poster Presentation: Radiologic tumor regression and pathologic correlation after neoadjuvant therapy for non-small cell lung cancer. Conference. 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. Chicago, IL, US.
- 2012. Poster Presentation: Factors associated with local control in inflammatory breast cancer. Conference. 2012 Breast Cancer Symposium. San Francisco, CA, US.
- 2011. Poster Presentation: Adult supratentorial ependymoma: The Mayo Clinic experience. Conference. 53rd Annual Meeting of the American Society for Radiation Oncology. Miami Beach, FL, US.
- 2011. Poster Presentation: Clinical outcomes of single and multifractionated SBRT schedules for spinal metastases. Conference. 53rd Annual Meeting of the American Society for Radiation Oncology. Miami Beach, FL, US.
- 2011. Poster Presentation: Maximum PTV dose predicts for radiation pneumonitis following lung stereotactic body radiation therapy. Conference. 53rd Annual Meeting of the American Society for Radiation Oncology. Miami Beach, FL, US.
- 2011. Oral Presentation: Stereotactic body radiation therapy in spinal metastases. Conference. 93rd Annual Meeting of the American Radium Society. Palm Beach, FL, US.
- 2011. Poster Presentation: Patient reported fatigue and overall survival in locally advanced esophageal cancer: A Mayo Clinic Adenocarcinoma and Barrett's Esophagus Registry Consortium study. Conference. 2011 Gastrointestinal Cancers Symposium. San Francisco, CA, US.
- 2010. Oral Presentation: Early stage primary bone lymphoma: A retrospective, multicenter rate cancer network study. Conference. 52nd Annual Meeting of the American Society for Radiation Oncology. San Diego, CA, US.
- 2010. Digital Poster Discussion: Early pulmonary toxicity of lung stereotactic body radiation therapy (SBRT) delivered as consecutive daily fractions. Conference. 52nd Annual Meeting of the American Society for Radiation Oncology. San Diego, CA, US.
- 2005. Poster Presentation: The functional effects of anti-hu14.18 antibody activity found in the serum of patients following IV infusion of immunocytokine (IC) hu14.18-IL2 for treatment of melanoma. Conference. 96th Annual Meeting of the American Association for Cancer Research. Anaheim, CA, US.
- 2005. Oral Presentation: Evaluation of human anti-human antibody responses in melanoma patients treated with hu14.18-IL2 immunocytokine. Invited. 46th Annual National Student Research Forum. Galveston, TX, US.
International Presentations
- 2022. DE-ESCALATION OF RADIATION THERAPY IN EARLY STAGE BREAST CANCER. Invited. Mexican Association of Mastology. Cancun, MX.
- 2020. How Should Radiation Be Done for IBC Patients. Invited. IBC International Conference Virtual Education Day, US.
- 2016. Post-operative radiation therapy after nipple-sparing or skin-sparing mastectom: When is indicated?. Invited. Annual Brazilian Radiotherapy Congress. Joao Pessoa, BR.
- 2016. Post-operative radiation therapy in patients with 1 - 3 positive nodes: When is indicated? What are the treatment fields?. Invited. Annual Brazilian Radiotherapy Congress. Joao Pessoa, BR.
- 2016. What are the available techniques strategies to improve planning target volumes coverage and decrease toxicities related to radiation therapy of the breast?. Invited. Annual Brazilian Radiotherapy Congress. Joao Pessoa, BR.
- 2011. Poster Presentation: Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for metastatic renal cell carcinoma. Conference. 3rd Annual EMUC Biennial Meeting. Barcelona, ES.
- 2011. Poster Presentation: Analysis of overall survival and self-reported fatigue in patients with esophageal cancer: a Mayo Clinic esophageal adenocarcinoma and Barrett's esophagus registry consortium study. Conference. ASCO 2011 Annual Meeting. Chicago, US.
- 2011. Early stage primary bone lymphoma: a retrospective, multicenter rare cancer network (RCN) study. Conference. 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO). Geneva, CH.
- 2010. Poster Presentation: Stereotactic Radiosurgery for Recurrent Intracranial Ependymoma. Conference. 15th Annual Scientific Meeting of the Society for Neuro-Oncology. Montreal, CA.
- 2009. Poster presentation: Excellent local control and long-term survival after intraoperative and external beam radiotherapy for pediatric solid tumors: long term follow-up of the Mayo Clinic experience. Conference. 91st Annual Meeting of the American Radium Society. Vancouver, CA.
- 2001. Poster Presentation: CD4 T-cell recognition of HLA DR15 restricted immunodominant epitopes in the non-structural proteins of HCV. Conference. 8th International Symposium of Hepatitis C and Related Viruses. Paris, FR.
Formal Peers
- 2024. Adjuvant Radiotherapy for Breast Cancer: Selection of Regional Lymph Drainage Area Irradiation. Invited. Concord Medical Group, CN.
- 2022. Controversies in the management of breast cancer. Invited. Mexican Association of Mastology. Cancun, MX.
- 2021. Radiotherapy after Neoadjuvant Treatment. Invited. Mexican Association of Mastology, MX.
- 2021. The Use of Breast Cancer Prognostic Factors and Radiotherapy Outcomes: MDACC experience. Invited. SHANGHAI Concord Cancer Center, CN.
- 2021. Navigating the Variability in Breast Contouring Guidelines. Invited. Singapore On Target (SPOT) Contouring Series, US.
- 2021. Recurrent Breast Cancer: Contouring and Current Practice. Invited. SHANGHAI Concord Cancer Center, CN.
- 2019. Radiotherapy in IBC: Different approach?. Invited. Inflammatory Breast Cancer International Consortium (IBC-IC), TN.
- 2018. An Update on the New AJCC Breast Cancer Staging Guidelines. Invited. OhioHealth. Columbus, OH, US.
- 2018. The Role of Oncotype Testing in Radiation Oncology. Invited. OhioHealth. Columbus, OH, US.
- 2018. DCIS and Early Breast Cancer; Locally Advanced Breast Cancer; Metastatic Breast Cancer and Palliative Care. Invited. University of Santo Tomas Hospital - Benavides Cancer Institute. Manila, PH.
- 2018. Topic of Advanced Radiation Therapies for Breast Cancer. Invited. Concord International Hospital, SG.
- 2017. Updates on Breast Immunotherapy Trials. Invited. Banner MD Anderson Cancer Center. Gilbert, AZ, US.
- 2016. Ablative Stereotactic Radiotherapy for Secondary Spinal Tumors: Targt Volume Delineation, Organs at Risk Delineation and Dose Constraints, Clinical Results Update. Invited. Albert Einstein Instituto Israelita de Ensino E Pesquisa. Sao Paulo, BR.
- 2016. Movement Management of Abdominal Tumors for SBRT. Invited. Albert Einstein Instituto Israelita de Ensino E Pesquisa. Sao Paulo, BR.
- 2016. Radiosurgery/Stereotactic Ablative Radiotherapy for Pancreatic Cancer. Invited. Albert Einstein Instituto Israelita de Ensino E Pesquisa. Sao Paulo, BR.
- 2016. Is There a Role for Hypofractionated Partial Irradiation and SBRT for Breast Cancers?. Invited. Albert Einstein Instituto Israelita de Ensino E Pesquisa. Sao Paulo, BR.
- 2013. Life After Mayo: Transitioning to a Career in Academic Medicine. Visiting. Mayo Clinic. Rochester, MN, US.
- 2012. Advanced Breast Cancer. Visiting. Mayo Clinic School of Radiotherapy. Rochester, MN, US.
- 2011. Pathologic Correlation of Radiotherapy Target Volumes in NSCLC: Implications for Adaptive and Proton Radiotherapy. Visiting. Mayo Clinic. Rochester, MN, US.
- 2011. Health Related Quality of Life and Patient Reported Fatigue in Esophageal Cancer. Visiting. University of California - San Francisco. San Francisco, CA, US.
- 2011. Patient Reported Fatigue and Health-related Quality of Life: A Pathway for Improved Clinical Outcomes?. Visiting. Mayo Clinic. Rochester, MN, US.
- 2011. Advanced Breast Cancer. Visiting. Mayo Clinic School of Radiotherapy. Rochester, MN, US.
- 2010. Uncommon Adverse Radiation Effects in the "Everyday" Clinic Experience. Visiting. Mayo Clinic School of Radiotherapy. Rochester, MN, US.
- 2010. Advanced Breast Cancer. Visiting. Mayo Clinic School of Radiotherapy. Rochester, MN, US.
- 2010. Unresectable Pancreatic Carcinoma. Visiting. Mayo Clinic. Rochester, MN, US.
- 2009. Inflammatory Breast Cancer. Visiting. Mayo Clinic. Rochester, MN, US.
Grant & Contract Support
| Date: | 2023 - 2026 |
| Title: | Quantifying temporal immunological changes with hypofractionated radiation-induced DNA damage in breast cancer |
| Funding Source: | ARTIDIS |
| Role: | Co-PI |
| ID: | 2021-0669 |
| Date: | 2017 - Present |
| Title: | RACHEL1: A Phase I Radiation and CHEckpoint bLockade trial in patients with metastatic hormone receptor positive / HER2 negative breast cancer |
| Funding Source: | EMD Serono (Merck) |
| Role: | Co-PI |
| Date: | 2016 - 2018 |
| Title: | Evaluation of DNA double strand break repair in breast cancer radiation-related toxicity |
| Funding Source: | Institutional Research Grand - MD Anderson Cancer Center |
| Role: | PI |
Patient Reviews
CV information above last modified March 06, 2025